Today, the CEO, Medical Segment of Cardinal Health (NYSE: CAH), Jon Giacomin, sold shares of CAH for $150.1K.
See today’s analyst top recommended stocks >>
Based on Cardinal Health’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $35.35 billion and GAAP net loss of $1.17 billion. In comparison, last year the company earned revenue of $32.97 billion and had a net profit of $274 million. CAH’s market cap is $16.35B and the company has a P/E ratio of 69.93. Currently, Cardinal Health has an average volume of 2.6M.
Based on 6 analyst ratings, the analyst consensus is Hold with an average price target of $57.60, reflecting a -10.3% downside.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cardinal Health, Inc. is a healthcare services company providing pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments.
